Updates and Advances in the Management of HS : Episode 4

Video

July 25, 2023

Emerging Agents for the Management of HS

Author(s):

Renata Block, MMS, PA-C

An expert in dermatology highlights emerging biologic therapy for the management of HS.

EP: 1.Overview of Hidradenitis Suppurativa (HS): A Multifactorial Disease

EP: 2.Approaching Treatment and Addressing Unmet Needs for Mild-to-Moderate HS

EP: 3.Role of Immunomodulation in HS Treatment

EP: 4.Emerging Agents for the Management of HS

EP: 5.SUNSHINE and SUNRISE Trials in HS

EP: 6.Overview and Diagnosis of Hidradenitis Suppurativa (HS)

EP: 7.Role of TNF-α Inhibitors in Moderate-to-Severe HS Treatment

EP: 8.Unmet Needs and Emerging Therapies in HS

EP: 9.Clinical Pearls for the Management of HS

EP: 10.Quality of Life for Patients With Hidradenitis Suppurativa (HS)

EP: 11.Diagnosis of HS

EP: 12.Treatment Options for HS

EP: 13.Emerging Therapy for Patients With HS

EP: 14.Clinical Pearls for Providers Treating HS

Related Videos

Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa

Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD

Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD

2 Additional Clinical Pearls for Dermatologists, with Eingun James Song, MD

2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD

What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?

New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD

Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action

Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.